Company: CGC
Filing Date: 2025-02-07
Form Type: 10-Q
Source: 0000950170-25-015839
Chunk: 82

Company: Canopy Growth Corp
Filing Date: 2025-02-07
Form: 10-Q
Item: Item 1
Chunk 82
---
 from continuing operations
     
    $
    (382,637
    )
     
    $
    (389,007
    )
     
    $
    6,370

    2
    %

    Net loss from continuing operations   attributable to Canopy Growth Corporation
     
    $
    (382,637
    )
     
    $
    (389,007
    )
     
    $
    6,370

    2
    %

    Basic and diluted loss per share from   continuing operations1
     
    $
    (4.15
    )
     
    $
    (5.56
    )
     
    $
    1.41

    25
    %

    1 For the nine months ended December 31, 2024, the weighted average number of outstanding common shares, basic and diluted, totaled 92,172,660 (nine months ended December 31, 2023 - 69,918,744).

Revenue

We report net revenue in four segments: (i) Canada cannabis; (ii) international markets cannabis; (iii) Storz & Bickel; and (iv) This Works. Revenue derived from the remainder of our operations are included within "other". The following table presents segmented net revenue for the nine months ended December 31, 2024 and 2023:

    Net Revenue
     
    Nine months ended December 31,

    (in thousands of Canadian dollars)
     
    2024

    2023

    $ Change

    % Change

    Canada cannabis

    Canadian adult-use cannabis1
     
    $
    58,424

    $
    71,848

    $
    (13,424
    )

    (19
    %)

    Canadian medical cannabis2

    57,059

    48,695

    8,364

    17
    %

    $
    115,483

    $
    120,543

    $
    (5,060
    )

    (4
    %)

    International markets cannabis3
     
    $
    32,166

    $
    29,666

    $
    2,500

    8
    %

    Storz & Bickel
     
    $
    56,315

    $
    48,517

    $
    7,798